Duchenne muscular dystrophy (DMD) is not currently part of mandatory newborn screening,
despite the availability of a test since 1975. In the absence of screening, a DMD diagnosis is …

Purpose Current and emerging treatments for Duchenne muscular dystrophy (DMD) position
DMD as a candidate condition for newborn screening (NBS). In anticipation of the …

Objective Duchenne muscular dystrophy (DMD) is an X‐linked disorder resulting in
progressive muscle weakness and atrophy, cardiomyopathy, and in late stages …

This report summarizes the progress made in newborn screening for Duchenne muscular
dystrophy (DMD). This subject was discussed fully at a symposium held on September 11 …

Duchenne muscular dystrophy (DMD) is the most common childhood form of muscular
dystrophy, with an estimated frequency of 1: 5000 live births. The impact of the disease …

Advancements in therapies for Duchenne muscular dystrophy (DMD) have made diagnosis
within the newborn period a high priority. We undertook a consortia approach to advance …

Background Duchenne muscular dystrophy (DMD/Duchenne) is a progressive X-linked
muscular disease with an overall incidence of 1: 5,000 live male births. Recent availability in …

Importance Duchenne muscular dystrophy (DMD) is a candidate for the recommended
universal screening panel based on evidence that early corticosteroid treatment improves …

Purpose. The purpose of this study was to assess the desirability of Duchenne muscular
dystrophy (DMD) screening, the effectiveness of the consent process, and the feasibility of …

Abstract Background Newborn screening for Duchenne muscular dystrophy (DMD) is
currently being initiated in Zhejiang Province, China and is under consideration in other …